Filing Details

Accession Number:
0000899243-23-002405
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-23 16:39:14
Reporting Period:
2023-01-19
Accepted Time:
2023-01-23 16:39:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659352 Codiak Biosciences Inc. CDAK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578407 Linda Bain C/O Codiak Biosciences, Inc.
35 Cambridgepark Drive, Suite 500
Cambridge MA 02140
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-19 5,000 $0.00 5,000 No 4 M Direct
Common Stock Disposition 2023-01-20 1,880 $0.58 3,120 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-01-19 5,000 $0.00 5,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 No 4 M Direct
Footnotes
  1. Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
  2. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
  3. Each RSU represents a contingent right to receive one share of common stock.
  4. On January 19, 2022, the reporting person was granted 15,000 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date.